History

Prior to founding Antibody Solutions, Dr. Kenney helmed the monoclonal antibody laboratory for Syntex Research and Ms. Lynch-Kenney was a marketing administrator for Syntex Labs in Palo Alto, California. By the time Syntex was acquired by Roche in 1994, the industry norm of performing almost all antibody discovery internally was changing. Companies began to favor contracting more specialized aspects of the antibody discovery process to contract research organizations.

The years 1999 to 2001 saw new innovations at Antibody Solutions on both technical and operational fronts. The company was an enabler and early adopter of tissue culture bioreactor flasks for the production of monoclonal antibodies, which took the place of mouse ascites production that was of animal welfare concern. Since that time, bioreactor production of antibodies has become a standard across the industry. The company also initiated the development of an enterprise resource database to govern its operations. This gave the company both the flexibility and scalability to deliver its expanding list of services to a growing client base.

As the company’s client base and service offerings continued to expand, Antibody Solutions outgrew its existing facility and relocated in 2011 to a larger office and lab space in Sunnyvale, California. At the same time, the firm began collaborating with human antibody transgenic animal providers: first with OMT (OmniAb®”), and later with Trianni, Harbour Antibodies™, and Alloy Therapeutics. This enabled Antibody Solutions to leverage its deep knowledge of animal-based antibody generation with the advantages of fully human antibodies for therapeutics development.In 2018, Antibody Solutions updated all of its brand messaging including a new logo, designed for AS by Inveniv.

Continued growth in the company’s team, client work, and facility needs propelled the company in 2019 to relocate once more, this time into a new 33,000 square-foot-plus facility in Santa Clara. Among the amenities of this new site are three conference rooms, each one named in memoriam for individuals whose contributions to the company’s development were immeasurable: Tony Allison, Barry Bredt, and Mary Welch. This move, which allows ample space for future expansion, coincided perfectly with Antibody Solutions’ 25th anniversary in 2020.

Included in Antibody Solutions’ plans for the future is an events space affectionately dubbed “The Salon.” This part of the facility hosted its first virtual symposium in July, 2020: "Working Through Adversity, Antibody Discovery, and the Pandemic." This space will host future in-person thought leadership-oriented gatherings for the greater California biotech community.